← FDA Drug Approvals (Drugs@FDA)
ASPIRIN AND DIPYRIDAMOLE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK SPECLT · Approved 2019-05-24
Drug application
- FDA Application #
ANDA210318- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ASPIRIN AND DIPYRIDAMOLE
- Generic name
- ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE
- Active ingredients
- ASPIRIN; DIPYRIDAMOLE
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- GLENMARK SPECLT
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- First approval
- 2019-05-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown